Background: Demyelination refers to the degradation or loss of myelin sheath. In demyelination model studies, it has been reported that demyelination is regressed by giving steroid hormones such as estrogen and progesterone. However, there are not many studies investigating the synthesis of these two hormones by the brain during demyelination and remyelination. Neurosteroids are steroid hormones synthesized by the brain independently from peripheral tissues. In this study, it was aimed to have knowledge about the synthesis of these two hormones by the brain in experimentally formed demyelination process in brains of C57BL/6 mice and their role in the cellular response formed in the region.
INTRODUCTION
Demyelination can occur because of ischemic, infectious and toxic causes. In diseases progressing with demyelination characterized by the loss of oligodendrocytes, demyelination is thought to be associated with oxidative stress, mitochondrial damage and microglial activation [6, 35] . This can activate astrocytes which can be both beneficial and harmful to the disease process [4, 5, 18, 33, 34, 36] .
When cuprizone was added to the diet of young male mice, it has been seen that demyelination was formed in central nervous system (CNS) and changes were determined in cellular, molecular, biochemical and morphological parameters around the lesions [22] . Following the damage occurred in CNS, some bioactive molecules with local protective effects are expressed from neurons and activated glial cells [14, 17] . Some of these are neurosteroid hormones synthesized from the brain independently from the gonads and adrenal glands.
Aromatase is an enzyme that catalyzes the synthesis of esrogen from the brain [1, 9, 32] . 3Beta hydroxysteroid dehydrogenase (3βHSD) is the enzyme that converts pregnenolone to progesterone. Expression of these two enzymes in the brain indicates the estrogen and progesterone synthesis in the brain [7] . When both estrogen and progesterone are given externally, oligodendroglial and neuronal death is prevented and myelin sheath synthesis is accelerated and the demyelination is regressed [8, 12, 26, 29, 30] .
With this study, it was aimed to have information about the role of estrogen and progesterone in the cellular response occurred in demyelination process by investigating the expression of neuro steroidogenic enzymes such as aromatase and 3βHSD from glial cells after the brain damage.
MATERIALS & METHODS

Animals
Three-month-old 36 male C57BL/6 mice with an average weight of 25 ± 5 g were used in the study. 12 of mice were used as a control group by feeding standard mouse diet for 12 weeks (Group I). 12 mice were fed 0.2% cuprizone diet for 8 weeks (Group II) and the rest 12 mice were fed 0.2% cuprizone diet for 8 weeks followed by normal diet for 4 weeks (Group III). Ad libitum access to drinking water was provided to all mice.
At the end of the study, necropsy was conducted to all mice following the cardiac perfusion with 4% paraformaldehyde under 3 mg/kg ketamine HCl anesthesia. After cardiac perfusion, animals' brains were removed and the sections were trimmed passing through the corpus callosum (CC) region. Trimmed brain samples were fixed in 4% paraformaldehyde solution for 24 h at +4°C, then washed under running water for one day and blocked in paraffin by treating with alcohol-xylol. Subsequently, 6 μm-thick sections were taken using the Rotary microtome (Leica, RM 2125) 1 . Luxol-Fast Blue (LFB) staining was performed histochemically to determine demyelination and remyelination in all tissue sections. Immunohistochemical (IHC) staining was performed on the tissues using avidin-biotin immunoperoxidase complex method. All tissue sections were deparaffinized in xylene and then rehydrated in graded alcohols. Then, antigen retrieval was performed for 20 min at 600 Watt and tissue sections were left to cool for 20 min. For endogenous peroxidase activity, they were kept in a methanol-3% hydrogen peroxide solution for 15 min. Sections were washed 3 times in phosphate buffer saline (PBS) for 5 min each. All sections were treated with block solution for 10 min and myelin basic protein (MBP) [ 
Assessment of demyelination
Histochemically LFB and immunohistochemically MBP-stained sections were blindly scored from 0 to 3 by two pathologists. In the control group fed with normal diet, the amount of myelin was expressed as 3, the amount of mild demyelination as 2, the amount of severe demyelination as 1, and the amount complete demyelination as 0 [23] .
Cell counting method
Sections taken passing through the CC region according to the brain atlas prepared by Harward University for C57BL/6 mice were immunohistochemically stained with GFAP, NG2, Aromatase and 3βHSD antibodies and the whole mentioned region was photographed with Nikon DS Camera 10 . For each antibody, each cell of which cytoplasm was positively stained was counted separately, and the results of all staining methods were evaluated statistically (Table 1) .
Statistical analysis
In the study, differences between the groups were analyzed using one-way analysis of variance technique according to the organs. Intergroup differences were investigated using DUNCAN multiple comparison test. In addition, introductory statistics for the groups were listed in Table 1 a, b, c the difference between group averages is statistically significant (P < 0.01). Average values obtained from median kind.
RESULTS
In the study, the amount of myelin obtained from the staining with LFB ( Figure 1 ) and MBP ( Figure 2 ) was evaluated by two pathologists. In the control group, group I, a complete myelination was detected while a severe demyelination was detected in group II, whereas in group III in which cuprizone was excluded from the diet, remyelination was formed and demyelination regressed to mild level.
In addition, in IHC staining performed with GFAP ( Figure 3 ) to determine astrocytes and with NG2 ( Figure 4 ) to determine young oligodendrocyte precursor (OPC) cells, low number of cells were positive stained in Group I which was the control group, whereas the number of positive stained cells were found to increase significantly in group II in which severe demyelination was detected. In the 3rd group in which demyelination regressed after exclusion of cuprizone from the ration and remyelination was formed, the number of positive stained cells was found to be higher than that in control group but less than that in the group II in which demyelination was formed (P < 0.01).
In IHC staining with aromatase ( Figure 5 ) and 3βHSD ( Figure 6 ) antibodies, there was no positive staining detected in glial cells in control group. In the group II in which demyelination occurred, positive stained glial cells were observed whereas, in the group III in which remyelination was formed, the number of positive stained cells was found to decrease significantly compared to group II (P < 0.01). 
DISCUSSION
Aromatase is the enzyme that catalyzes the synthesis of estrogen [1] The expression of aromatase in the brain is very low under normal conditions and is limited to neurons [13, 19, 20] . However, it has been found that the expression of aromatase from neurons increases, thus the level of local estrogen increases after experimentally formed neuronal damage [8,9,24]. The investigations conducted have suggested that the increase in estrogen level associated with neuronal damage may be a protective feature specific to brains of vertebrates and may be an important component in the initiation of a neuronal response to damage [8, 9, 24] .
Progesterone has been reported to play an important role in regeneration of neurons and myelin formation [25, 37] . 3βHSD catalyzes the progesterone synthesis and expression of 3βHSD from tissues indicates progesterone synthesis in the region [11] .
In the study conducted by Taylor et al. [31] C57BL/6 mice were fed cuprizone diet and demyelination was formed, while estrogen was given as a subcutaneous implant to another group at the same time. They have found mature oligodendrocyte loss, microglial accumulation, and decreased IGF-1 and TNFα release in the group in which implant was applied compared to the group in which implant was not applied. Besides prevention of apoptosis of oligodendrocytes by giving estrogen externally, they have found that IGF-1 release can also be reduced suppressing microglia and astrocyte activation, thus demyelination can partially be prevented by the reduction of harmful substances such as TNFα released from these cells [31] .
Another study has reported that while forming demyelination with cuprizone in C57BL/6 mice, giving progesterone with estrogen externally at the same time was found to be more beneficial than the effect of estrogen alone on demyelination [23] . Contrary to Taylor et al. [31] , Peter et al. [23] have emphasized that co-administration of estrogen and progesterone increases the number of astrocytes and demyelination can be greatly inhibited by stimulation of IGF-1 release from glial cells. These two studies conducted are the closest ones to the presented study in terms of animal used and demyelination model. However, unlike these two studies, estrogen and progesterone were not externally administered during demyelination process but it is thought that aromatase and 3βHSD enzymes were expressed from the astrocytes in the region, and accordingly, progesterone and estrogen were synthesized in the damaged region. There are studies showing that the level of aromatase expressed from the neurons in the region increases after neuronal damage [8, 9, 24] . However, there is one study in which aromatase is expressed from glial cells after demyelination [34] .
Aromatase enzyme expression from glial cells increased in demyelination formed during distemper [34] . In the study conducted by Yarim et al. [34] they have found that aromatase expression was very low from astrocytes in the cerebellum of dogs, whereas aromatase expression of astrocytes in demyelination region in cerebellum of animals with distemper increased. In presented study, aromatase expression was observed in the group in which demyelination occurred, while the aromatase expression from glial cells was not observed in the CC region of brain of mice in control group. It is believed that the difference observed in control group animals in two mentioned studies are likely to vary according to the animal species or the different regions of the CNS.
Although there is no study showing that progesterone is synthesized in the brain during demyelination, there are studies reporting that the externally given progesterone regresses demyelination [23, 25, 34, 37] . In the study, it was found that young OPC and astrocytes in the region proliferated besides estrogen and progesterone synthesis during demyelination [23] . Although the pathogenesis was not clear, it is thought that the level of these two neurosteroid hormones may increase in order to protect the brain during demyelination and that cellular proliferation may initiate the signaling stages for remyelination. Because in the study, when the cuprizone was excluded from the diet, remyelination was formed in the region again and the OPC increase, glial activation and hormone expressions began to decrease significantly [8, 9, 13, 19, 20, 24] .
These results suggest that damage in the brain can be repaired at a certain level without any treatment or stimulant applied externally when the effect causing damage in the brain is removed. These findings are thought to be important in the brain, which is vital, and does not have regeneration feature. However, this mechanism is complex and full of assumptions. It is a strong assumption that estrogen and progesterone synthesized in response to the damage in the area was the effect initiating remyelination in the study.
It has been reported that CNS cells, especially astrocytes, are important in the MS-related demyelination and remyelination mechanism and demyelination can progress as a result of the increase of inflammatory cytokines released from astrocytes with the proliferation of these cells, and apoptosis of oligodendrocytes because of cuprizone [28] . On the other hand, it has been reported that estrogen stimulates the release of various growth factors from reactivated astrocytes when given externally, and that these growth factors accelerate remyelination by inhibiting oligodendrocyte apoptosis and providing OPC migration to the region with lesion [8, 15, 31] . Estrogen can also stimulate progesterone synthesis from astrocytes by stimulating them [21, 27] . It is not known which mechanism stimulated the synthesis of aromatase from glial cells in this presented study, however, it is thought that in some way there may be a compensation mechanism in response to demyelination. Aromatase expression from glial cells may have initiated local estrogen production in CC region of brain. Estrogen synthesis can trigger local synthesis of progesterone from astroglial cells by stimulating their proliferation just as in studies in which estrogen was given externally [3, 11, 16, 21, 27] .
The results of this study support the hypothesis suggesting that progesterone can regress demyelination by stimulating OPC migration to the region of demyelination and inhibiting oligodendrocyte apoptosis [9, 15, 23, 28, 31] . Because, in the study, OPC migration was detected with the proliferation of astrocytes in the region of demyelination.
As a result, estrogen and progesterone synthesized with the activation of the protective mechanism during demyelination in the brain may not provide a fast recovery as the estrogen and progesterone given externally. However, knowing the existence of such mechanism can be a step for future studies, and perhaps with more extensive studies, results that can make this mechanism more active in humans and animals before the damage reaches a critical level during diseases characterized with demyelination, can be obtained.
CONCLUSIONS
Increased expression levels of steroidogenic enzymes such as aromatase and 3βHSD in the glial cells following demyelination could increase estrogen and progesterone and this contribute significantly through regression of the demyelination and progression of the remyelination. Nikon Imaging Japan Inc.Tokyo, Japan.
